Pfizer, Inc.

Good day, everyone, and welcome to Pfizer's third quarter 2020 earnings conference call. Today's call is being recorded. At this time, I would like to turn the call over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Go ahead, sir.

Thank you, Operator. Good morning, and thanks for joining us today to review Pfizer's third quarter 2020 financial results, our updated 2020 financial guidance, Pfizer's role in helping find solutions for the COVID-19 pandemic, as well as other relevant business topics. I'm joined today as usual by our chairman and CEO, Dr. Albert Borla, Frank D'Amelio, our CFO, Michael Dolston, our Chief Scientific Officer and President of Worldwide Research Development and Medical, Angela Wong, Group President, Pfizer Biopharmaceuticals Group, John Young, our Chief Business Officer, and Doug Lankler, our General Counsel. The slides that will be presented during the call were posted to our website earlier this morning and are available at Pfizer.com forward slash investors.

With Fundrise, you can invest here, from there, or there, from here. Our platform gives you access to premium real estate that was previously only available to institutions. So you can take your portfolio from here to there. You'll get updates on this and that from wherever you are. Join the community of over 150,000 investors that have gone from there to here with Fundrise.